证券代码：601567 证券简称：三星医疗 公告编号：临 2025-060 宁波三星医疗电气股份有限公司 关于回购股份注销实施暨股份变动公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 公司于2023年12月7日召开第六届董事会第六次会议，并于2023年12月25日 召开2023年第四次临时股东大会，审议通过了《关于回购公司股份方案的议案》。 同意公司使用自有资金以集中竞价的方式回购公司股份，回购资金总额不低于人 民币1.5亿元（含），不超过人民币3亿元（含），回购价格不超过人民币21.00 元/股。具体内容详见公司分别于2023年12月8日、2023年12月26日披露于上海证 券交易所网站的公告《三星医疗关于回购公司股份预案的公告》（公告编号：临 （公告编号：临2023-103）。 （二）回购股份实施情况 关于以集中竞价交易方式首次回购公司股份的公告》（公告编号：临2023-105）。 为19.30元/股，已支付的资金总额为人民币279,083,618.90元（不含印花税及交易 佣金等费用）。回购方案实际 ...

Core Viewpoint - The company has approved a share buyback plan to reduce registered capital by repurchasing shares using its own funds, with a total buyback amount ranging from RMB 120 million to RMB 240 million [2][3]. Buyback Plan Details - The buyback will be conducted through the Shenzhen Stock Exchange, targeting A-shares, with a maximum repurchase price set at RMB 39 per share initially, later adjusted to RMB 38.26 and then to RMB 37.28 [2][3][4]. - The estimated number of shares to be repurchased ranges from approximately 3,076,923 shares (0.77% of total shares) to 643,780 shares (1.61% of total shares) based on the maximum buyback amount [2][3]. Implementation Status - As of July 18, 2025, the company has repurchased a total of 4,265,977 shares, representing 1.07% of the total share capital, with a total transaction amount of approximately RMB 121.89 million [3][4]. - The highest transaction price during the buyback was RMB 30.07 per share, and the lowest was RMB 27.72 per share, with an average price of RMB 28.57 per share [3]. Share Cancellation - The company completed the cancellation of the repurchased shares on July 25, 2025, reducing the total share capital from 400,010,000 shares to 395,744,023 shares [3][4]. - The cancellation of shares will not significantly impact the company's operations, finances, or future development [4]. Share Structure Changes - Following the cancellation, the proportion of restricted shares increased from 78.49% to 79.34%, while the proportion of unrestricted shares decreased from 21.51% to 20.66% [4].

Group 1 - The company has completed the repurchase and cancellation of H shares, resulting in a reduction of total share capital from 233,193,695 shares to 232,581,095 shares [1][2] - The repurchase was authorized during the 2023 annual general meeting and subsequent shareholder meetings, allowing the board to proceed with the cancellation of H shares [1] - Following the cancellation, the structure of the share capital has changed, with A shares increasing from 83.2149% to 83.4341% of total shares, while H shares decreased from 16.7851% to 16.5659% [2]

Core Viewpoint - The company has completed the cancellation of repurchased shares, which will positively impact its capital structure and shareholder returns [2][7][8]. Group 1: Share Repurchase and Cancellation Details - The company repurchased a total of 97,215,300 shares in 2024, with 80,115,300 shares being canceled, representing 82.41% of the repurchased shares and 5.4% of the total shares before cancellation [2][7]. - The total amount for the canceled shares was RMB 246,695,724.11, and after the cancellation, the total share capital decreased from 1,483,934,025 shares to 1,403,818,725 shares [2][7][8]. - The repurchase was approved by the board on January 10, 2024, and the total funds allocated for the repurchase were increased from RMB 5 million to a range of RMB 15 million to RMB 30 million [2][3]. Group 2: Impact on Shareholder Structure - Following the cancellation, the controlling shareholder, Hualian Group, saw its ownership percentage increase from 28.21% to 29.82% without changing the number of shares held [7][8]. - This change in ownership percentage does not trigger a mandatory tender offer and does not affect the company's governance structure or ongoing operations [8]. Group 3: Financial Implications - The cancellation of shares is treated as a cash dividend, with the amount equivalent to the repurchase value of RMB 246,695,724.11, enhancing earnings per share and net asset value [8][9]. - The company asserts that this action will not significantly impact its financial condition, debt repayment ability, or shareholder equity [8].

证券代码：002195 证券简称：岩山科技 公告编号：2025-042 上海岩山科技股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、 误导性陈述或者重大遗漏。 特别提示： （以下简称"公司"）总股本的 0.19%。本次注销完成后，公司总股本由 5,681,544,596 股 变 更 为 5,670,554,696 股 ， 公 司 注 册 资 本 由 人 民 币 5,681,544,596 元 变 更 为 事宜已于 2025 年 7 月 22 日办理完成。 公司因实施注销回购专用证券账户股份导致公司总股本、无限售条件流通股数量发生 变化，根据《上市公司股份回购规则》《深圳证券交易所上市公司自律监管指引第 9 号— —回购股份》等相关规定，现就回购股份注销完成暨股份变动情况公告如下： 一、本次回购股份的批准和实施情况 公司已于 2025 年 7 月 22 日在中国证券登记结算有限责任公司深圳分公司办理完毕 上述 10,989,900 股回购股份的注销事宜。本次回购股份的数量、完成日期、注销期限符 合回购股份注销相关法律法规的要求，与回购方案不存在差异。 三、本次回购股份注销后 ...

Core Viewpoint - The company intends to change the purpose of its repurchased shares from employee stock ownership plans and maintaining shareholder value to cancellation of shares to reduce registered capital [1][7]. Group 1: Share Repurchase Details - The company plans to change the use of 1,230,216 repurchased shares, which represents 1.2175% of the current total share capital [1][7]. - The total share capital will decrease from 101,043,920 shares to 99,813,704 shares after the cancellation [6][7]. - The repurchased shares were initially intended for employee stock ownership plans and maintaining shareholder value, with a maximum repurchase price of RMB 28.00 per share and a total repurchase fund between RMB 20 million and RMB 40 million [2][3]. Group 2: Rationale and Impact - The decision to change the purpose of the repurchased shares is aimed at enhancing investor returns and confidence, thereby increasing the company's long-term investment value [3][7]. - The cancellation of shares is expected to increase earnings per share and improve shareholder returns without adversely affecting the company's financial condition or debt servicing ability [7][8]. - The company asserts that this change complies with relevant regulations and will not harm the interests of shareholders, particularly minority shareholders [7][8]. Group 3: Decision-Making Process - The board of directors approved the proposal during the meetings held on July 21, 2025, and it will be submitted for shareholder approval [8].

Group 1 - The core viewpoint emphasizes the importance of the capital market in promoting technological progress and supporting the development of innovative enterprises in China [1] - The capital market should be recognized as a crucial hub in the economic development and financial system construction of China, moving beyond a simplistic view of it as merely a financing market [2] - The capital market encompasses both narrow and broad definitions, including venture capital and angel investments, which are essential for sustainable development [2] Group 2 - Enhancing the competitiveness of listed companies is fundamental for the stable development of the capital market, with a focus on the quality of companies rather than just their current profitability [4] - Modern financial theories have evolved, indicating that asset pricing now considers technological progress and innovation as key factors, rather than solely relying on profit [5] - Effective tools such as share buybacks can enhance company value by reducing the number of circulating shares, thereby increasing earnings per share [5] Group 3 - Small enterprises play a significant role in the economy, as all large companies originate from smaller ones, and they require support to grow and enhance overall market competitiveness [6] - Issues such as the backlog of companies waiting to go public and the prevalence of hidden risks in listed companies need to be addressed through reforms and improved regulatory frameworks [7] - The importance of market fairness and transparency is highlighted, as it directly impacts the overall health of the capital market [7]

Core Viewpoint - The company has completed the repurchase and cancellation of shares, resulting in a reduction of total share capital from 828,127,200 shares to 824,283,100 shares [1][5][6] Summary by Sections Share Repurchase Approval - The company approved a share repurchase plan on June 24, 2024, allowing for the use of between RMB 20 million and RMB 40 million to repurchase shares at a price not exceeding RMB 2.61 per share within 12 months [1][2] Share Repurchase Implementation - A total of 3,872,800 shares were repurchased, accounting for 0.47% of the total shares before cancellation, with a total expenditure of RMB 9,987,924.00 [2][4] Share Cancellation Arrangement - The cancellation of 3,844,100 shares was completed on July 17, 2025, resulting in a new total share capital of 824,283,100 shares [5][6] Impact of Share Cancellation - The cancellation is expected to enhance earnings per share and improve shareholder returns without significantly affecting the company's financial status or future development [5][6] Follow-up Arrangements - The company will proceed with necessary changes in business registration and documentation following the completion of the share repurchase plan [6]

Group 1 - The company plans to repurchase shares using its own funds, with an amount between RMB 3 million and RMB 5 million, at a price not exceeding RMB 27.72 per share [1][2] - The repurchased shares will be canceled, leading to a reduction in the company's registered capital [1][2] - The specific number of shares repurchased and the proportion of total share capital will be determined upon completion of the repurchase or expiration of the repurchase period [1] Group 2 - Creditors are informed that they can request the company to settle debts or provide guarantees due to the capital reduction from the share repurchase [2] - Creditors must submit written requests along with relevant proof of debt relationships, such as contracts or agreements, to the company [2] - The company provides contact information for creditors to declare their claims, with specific instructions for both in-person and mail submissions [3]

Group 1 - The company announced a share repurchase plan at a price of RMB 1.00 per share, which will lead to a reduction in registered capital [1] - The decision was made during the 2024 annual shareholders' meeting held on June 6, 2025, where the performance commitment and impairment testing of major asset restructuring were discussed [1] - Creditors are informed that they can request debt repayment or guarantees upon receiving the notice, and failure to act within the specified period will not affect the validity of their claims [1][2] Group 2 - Creditors must provide original and photocopied documents proving the existence of the debt relationship when declaring their claims [2] - For corporate creditors, additional documents such as the business license and identification of the legal representative are required [2] - The company provides contact information for creditors to submit claims via mail or in person, with specific instructions for mail submissions [2]